$AMRN Headlines Expedia falls on Google penalty; Alcoa

New Post Public Reply Private Reply Replies (0) Message Board

May 15, 2014 at 12:04 PM

$AMRN Headlines

Expedia falls on Google penalty; Alcoa jumps on upgrade 4:54 p.m. Jan. 21, 2014 - Sue Chang
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Intercept, Celgene on move amid J.P. Morgan event 10:20 a.m. Jan. 13, 2014 - Victor Reklaitis
6 gut checks before the stock market's opening bell 7:12 a.m. July 8, 2013 - Shawn Langlois
6 gut checks before the stock market's opening bell 7:55 a.m. March 27, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:05 a.m. Feb. 27, 2013 - Shawn Langlois
Friday’s big movers: Groupon soars on Google talk 5:38 p.m. Dec. 7, 2012 - Sue Chang
Amarin down 17% on risks tied to drug launch 9:00 a.m. Dec. 7, 2012 - Steve Gelsi
Amarin down 18% in premarket trades 8:41 a.m. Dec. 7, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 4:40 p.m. Oct. 10, 2012 - Sue Chang
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Amarin issues patent update on fish-oil drug 12:29 p.m. Sept. 5, 2012 - Val Brickates Kennedy
Amarin jumps 16% after business update 12:06 p.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin rallies 15% on business update 10:48 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin falls 11% on insider stock-sale reports 12:12 p.m. July 31, 2012 - Val Brickates Kennedy
Amarin, AuthenTec active; advancers outpace decliners 4-1 on NYSE 12:45 p.m. July 27, 2012 - blogs.marketwatch.com
Amarin down 9% in wake of drug approval 10:08 a.m. July 27, 2012 - Val Brickates Kennedy
Amarin gets FDA approval for Vascepa 6:09 p.m. July 26, 2012 - Wallace Witkowski
Amarin: FDA OKs Vascepa for high triglycerides 5:46 p.m. July 26, 2012 - Wallace Witkowski
Amarin halted ahead of FDA decision deadline 3:13 p.m. July 26, 2012 - Val Brickates Kennedy

Top Analyst Upgrades and Downgrades: Amarin, Boeing, Cisco, KKR, NetApp, Twitter and More 8:01 a.m. May 12, 2014 - 247WallSt.com
Amarin's (AMRN) CEO John Thero on Q1 2014 Results - Earnings Call Transcript 12:20 p.m. May 9, 2014 - Seeking Alpha
More on Amarin Q1 results 7:37 a.m. May 9, 2014 - Seeking Alpha
10-Q: AMARIN CORP PLC\UK 7:10 a.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Move over Vascepa, here comes Epanova 7:08 a.m. May 6, 2014 - Seeking Alpha
Amarin Takes Step 1, Of A Million, To Right Its Ship 3:21 p.m. April 1, 2014 - Seeking Alpha
Amarin: How The Co-Promotion Agreement With Kowa Affects Required Sales Targets 12:53 a.m. April 1, 2014 - Seeking Alpha
Amarin +4.4% AH on U.S. Vascepa co-promotion deal 5:03 p.m. March 31, 2014 - Seeking Alpha
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks' 7:00 a.m. March 21, 2014 - TheStreet.com
Are Biotech Stocks Located in Ireland Top Buyout Candidates? 9:34 a.m. March 19, 2014 - 247WallSt.com
Amarin Management Discusses Q4 2013 Results - Earnings Call Transcript 10:20 p.m. Feb. 27, 2014 - Seeking Alpha
10-K: AMARIN CORP PLC\UK 4:14 p.m. Feb. 27, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Thursday’s close 5:35 p.m. Feb. 26, 2014 - Seeking Alpha
Amarin Is Likely Now A Vortex Where Your Money Will Go To Die 2:16 p.m. Feb. 26, 2014 - Seeking Alpha
What Now For Amarin? 2:54 p.m. Feb. 25, 2014 - Seeking Alpha
Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog 5:20 p.m. Feb. 24, 2014 - Zacks.com
Amarin fair value target cut at MKM after FDA decision 3:16 p.m. Feb. 24, 2014 - Seeking Alpha
Amarin Loses Bid for Vascepa 5-Year Market Exclusivity 7:59 a.m. Feb. 24, 2014 - TheStreet.com
Amarin's Vascepa given marketing exclusivity, shares +4.8% AH 4:22 p.m. Feb. 21, 2014 - Seeking Alpha

Amarin Announces Private Exchange Transactions Regarding Outstanding Senior Exchangeable Notes 5:00 a.m. Today - GlobeNewswire
Amarin Reports First Quarter 2014 Financial Results and Provides Update on Operations 7:01 a.m. May 9, 2014 - GlobeNewswire
Amarin to Report First Quarter 2014 Results and Host Conference Call on May 9, 2014 8:01 a.m. May 5, 2014 - GlobeNewswire
Amarin Announces Presentation of New MARINE and ANCHOR Post-Hoc Analyses at National Lipid Association Annual Scientific Sessions Showing Vascepa(R) Significantly Reduced Apolipoprotein C-III Levels 8:02 a.m. May 2, 2014 - GlobeNewswire
Technical Roundup on Health Care Stocks -- Research on Amarin, United Therapeutics, Hologic, and NxStage Medical 2:10 p.m. April 25, 2014 - PR Newswire - PRF
Amarin Corp. and Kowa Pharmaceuticals to Begin Joint Vascepa Promotion in May 12:25 p.m. April 11, 2014 - ACCESSWIRE
Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules 4:37 p.m. March 31, 2014 - GlobeNewswire
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 12:19 p.m. March 28, 2014 - PR Newswire - PRF
Amarin Corporation plc. Analyst Report: Special Situation \ Turnaround Opportunity in Biopharmaceuticals - Targeting large existing cardiovascular health market by BrokerBank Securities, Inc. 7:00 a.m. March 28, 2014 - PR Newswire - PRF
Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations 5:14 p.m. Feb. 27, 2014 - GlobeNewswire
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview 2:59 p.m. Feb. 24, 2014 - PR Newswire - PRF
Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014 7:00 a.m. Feb. 24, 2014 - GlobeNewswire
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules 5:01 p.m. Feb. 21, 2014 - GlobeNewswire
Amarin to Present at the 2014 Leerink Global Healthcare Conference 7:30 a.m. Feb. 6, 2014 - GlobeNewswire
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales 7:00 a.m. Feb. 4, 2014 - GlobeNewswire
Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request 2:00 a.m. Jan. 21, 2014 - GlobeNewswire
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed 5:05 p.m. Jan. 15, 2014 - GlobeNewswire
Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer 9:00 a.m. Dec. 27, 2013 - PR Newswire
New Drug Application Updates, Appointments, Partnership Programs, and Stock Movements - Research Report on Amarin, Oramed Pharmaceuticals, Synta Pharmaceuticals, Healthways and AMN Healthcare 9:00 a.m. Dec. 25, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and of a Lead Plaintiff Deadline of January 3, 2014 4:29 p.m. Dec. 24, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Shanghai Biennale: LOUDER Brings Culture to Forefront

Shanghai and the Cultural Pulse of 2027 The 16th Shanghai Biennale is making some noise, and it's got a fitting title to match: LOUDER. Set to take the stage in November 2027, hosted by the Power Station of Art and curated by Ferran Barenblit, it's all about the soundtrack and visual kaleidoscope of our lives—a reminder that we're not just consumers of culture but...

LiuGong Pushes Sustainability at 2026 Dealer Conference

The Road to Green: LiuGong’s Ambitious Vision In a world where more heads are turning towards sustainability, LiuGong stepped up and showcased its green aspirations with flare at the 2026 Global Dealer Conference held from November 10 to 12 in Liuzhou, China. Over 2,000 attendees, ranging from dealers to customers, were in attendance to witness what seemed to be both a...

Data Center Cooling: Air vs. Liquid Battle Heats Up

Cooling Market: A Hot Green Showdown Here's the scene: data centers, churning out digits like a Wall Street broker spits out numbers, are in the middle of a seismic shift. We're talking about the cooling sector jumping from $19.5 billion in 2026 to a mind-boggling $42 billion by 2031. Now that's more of a leap than a hop, if you ask me. But the rocket fuel behind this...

CPC Biotech Debuts Quattroflow HTX Pump Drive

By Henry Turner Updated Nov 11, 2026 Category News Views 136

Innovative Moves in Bioprocessing Let's get one thing clear right off the bat—CPC Biotech, part of Dover (NYSE: DOV), just sent a signal loud and clear with their new Quattroflow HTX all-in-one pump drive. With a slick touchscreen, flexible control options, and self-touting accuracy, this thing sounds like it's set to change the game for biopharmaceutical processing....

Maryland American Water Offers Key Service Tips

When Water Becomes Front Page News You'd think something as basic as water wouldn't need much chatter. Yet, when the taps go dry, people panic like there's no tomorrow. American Water (NYSE: AWK) is looking to keep that at bay, with their latest tips on staying ahead of any potential water service hiccups. Let's be real: their service underpins everything, from your...

Q32 Bio's Ambitious Steps into Global Conferences

Q32 Bio Takes the Stage at Jefferies Who would've thought? Q32 Bio, strutting their stuff at the 2026 Jefferies Global Healthcare Conference in London. Mark your calendars, folks, for November 18, 2026, because that's when they're jumping into the spotlight with a fireside chat. This event isn't just another tiny ripple; it's a chance for Q32 to showcase their innovative...

EF English Live: Boosting Careers with Language Skills

Riding the English Proficiency Wave for Career Growth Everyone knows that being able to speak English is more than just a golden ticket to deeper Netflix rabbit holes; it's a damn necessity if you're dealing with global markets. You get those international clients on the line, and suddenly, your high school French isn't doing much for you. Take EF English Live, a platform...

Endava Faces Class Action Over Misleading Accounting

Endava's Accounting Woes: A Deep Dive Look, if you're holding onto Endava plc (NYSE: DAVA) shares, it's time to perk those ears up. There's a class action lawsuit cooking, and it's all about how Endava misled folks about some tricky accounting tricks—something about fudging the books with customer and supplier agreements. That's putting a lot of people's hard-earned...

Gulliver Prep's New STEAM Complex to Transform Miami

Gulliver Prep Leads the Charge in Education Innovation Gulliver Preparatory School just dropped a bombshell in Miami—almost literally, with their shovels hitting the dirt for a new 95,000-square-foot STEAM complex. It's not some lip-service to educational buzzwords either. This project's part of 'The Next 100: The Centennial Campaign for Gulliver,' a mega drive to...

Woolery & Co Boosts M&A Expertise with Debbie Wang

A New Power Player Joins Woolery & Co Let me tell you, every now and then a firm makes a move that absolutely oozes strategic brilliance, and this right here is one of those moments. Woolery & Co, a name that's been making waves in strategic advisory circles, has just added Debbie Wang to their lineup. If you're not familiar, she's fresh from Ropes & Gray LLP where she...